MedTrace Logo

Impact of Home Exercise Delivery on Compliance & Outcomes for Musculoskeletal Pain

NCT03470753 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 116

Last updated 2020-01-18

No results posted yet for this study

Summary

Patients seeking care for chronic low back or knee pain will be recruited for enrollment, and randomized within two phases (retention and compliance). Patients will consent to a 2-step study design, with independent randomization for each. The initial step will assess retention based on 4 different exercise prescription strategies. This will be assessed short-term, and then the 2nd step will consist of a second independent randomization to receive different reminder strategies to determine their influence on exercise compliance at home.

Conditions

  • Chronic Pain
  • Compliance, Patient
  • Chronic Low Back Pain
  • Knee Pain Chronic

Interventions

OTHER

Number of Exercises

Subjects will receive either 2 or 4 exercises to evaluate the short-term recall and performance.

OTHER

Type of Instruction

The type of instruction in phase 1 will be compared: Instruction by providing a handout only vs being instructed by a provider and practiced by the patient with provider feedback.

OTHER

Delivery Type

In phase 2 subjects will be provided 4 exercises using only a handout vs delivered to them electronically with the addition of a video.

OTHER

Mobile Reminder

A text-message based mobile reminder tool will be utilized to engage with subjects via texting on a daily basis to provide reminders and encouragement to perform their home exercises.

Sponsors & Collaborators

  • Dan Rhon

    lead FED

Principal Investigators

  • Daniel Rhon, DSc · Brooke Army Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-12
Primary Completion
2019-06-30
Completion
2019-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03470753 on ClinicalTrials.gov